Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore how a sarcoma is affected by and the side effects of
a newer combination of chemotherapy drugs(gemcitabine and docetaxel)as compared to a standard
combination of chemotherapy drugs, ifosfamide and doxorubicin.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center